Publication:
The psoriatic arthritis registry of Turkey: Results of a multicentre registry on 1081 patients

dc.contributor.buuauthorÖksüz, Mustafa Ferhat
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentİç Hastalıkları Ana Bilim Dalı
dc.contributor.departmentRomatoloji Ana Bilim Dalı
dc.contributor.scopusid56016440100
dc.date.accessioned2023-08-08T07:29:18Z
dc.date.available2023-08-08T07:29:18Z
dc.date.issued2016-09-09
dc.descriptionÇalışmada 48 yazar bulunmaktadır. Bu yazarlardan sadece Bursa Uludağ Üniversitesi mensuplarının girişleri yapılmıştır.
dc.description.abstractObjective. The aim was to assess the characteristics of PsA, find out how well the disease is controlled in real life, demonstrate the treatments and identify the unmet needs. Methods. The PsA registry of Turkey is a multicentre Web-based registry established in 2014 and including 32 rheumatology centres. Detailed data regarding demographics for skin and joint disease, disease activity assessments and treatment choices were collected. Results. One thousand and eighty-one patients (64.7% women) with a mean (S.D.) PsA duration of 5.8 (6.7) years were enrolled. The most frequent type of PsA was polyarticular [437 (40.5%)], followed by oligoarticular [407 (37.7%)] and axial disease [372 (34.4%)]. The mean (S.D.) swollen and tender joint counts were 1.7 (3) and 3.6 (4.8), respectively. Of these patients, 38.6% were on conventional synthetic DMARD monotherapy, 7.1% were on anti-TNF monotherapy, and 22.5% were using anti-TNF plus conventional synthetic DMARD combinations. According to DAS28, 86 (12.4%) patients had high and 105 (15.2%) had moderate disease activity. Low disease activity was achieved in 317 (45.7%) patients, and 185 (26.7%) were in remission. Minimal disease activity data could be calculated in 247 patients, 105 of whom (42.5%) had minimal disease activity. The major differences among sexes were that women were older and had less frequent axial disease, more fatigue, higher HAQ scores and less remission. Conclusion. The PsA registry of Turkey had similarities with previously published registries, supporting its external validity. The finding that women had more fatigue and worse functioning as well as the high percentage of active disease state highlight the unmet need in treatment of PsA.
dc.identifier.citationKalyoncu, U. vd. (2017). ''The psoriatic arthritis registry of Turkey: Results of a multicentre registry on 1081 patients''. Rheumatology, 56(2), 279-284.
dc.identifier.endpage286
dc.identifier.issn1462-0324
dc.identifier.issn1462-0332
dc.identifier.issue2
dc.identifier.pubmed27794533
dc.identifier.scopus2-s2.0-85039809580
dc.identifier.startpage279
dc.identifier.urihttps://doi.org/10.1093/rheumatology/kew375
dc.identifier.urihttps://academic.oup.com/rheumatology/article/56/2/279/2447889
dc.identifier.urihttp://hdl.handle.net/11452/33393
dc.identifier.volume56
dc.identifier.wos000397050600018
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherOxford University
dc.relation.collaborationYurt içi
dc.relation.collaborationYurt dışı
dc.relation.collaborationSanayi
dc.relation.journalRheumatology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectPsoriatic arthritis
dc.subjectRegistry
dc.subjectDisease activity
dc.subjectInflammatory back-pain
dc.subjectAnkylosing-spondylitis
dc.subjectClinical history
dc.subjectDisease-activity
dc.subjectHealth-care
dc.subjectClassificationcriteria
dc.subjectCriteria
dc.subjectSpondyloarthritis
dc.subjectRecommendations
dc.subjectPrevalence
dc.subject.emtreeAdalimumab
dc.subject.emtreeDisease modifying antirheumatic drug
dc.subject.emtreeEtanercept
dc.subject.emtreeGlucocorticoid
dc.subject.emtreeGolimumab
dc.subject.emtreeInfliximab
dc.subject.emtreeMethotrexate
dc.subject.emtreeTumor necrosis factor inhibitor
dc.subject.emtreeAntirheumatic agent
dc.subject.emtreeTumor necrosis factor
dc.subject.emtreeAdult
dc.subject.emtreeArthralgia
dc.subject.emtreeArticle
dc.subject.emtreeAxial disease
dc.subject.emtreeCombination drug therapy
dc.subject.emtreeDAS28
dc.subject.emtreeDisease activity
dc.subject.emtreeDisease control
dc.subject.emtreeDisease duration
dc.subject.emtreeFatigue
dc.subject.emtreeFemale
dc.subject.emtreeHealth assessment questionnaire
dc.subject.emtreeHealth care need
dc.subject.emtreeHuman
dc.subject.emtreeJoint swelling
dc.subject.emtreeMajor clinical study
dc.subject.emtreeMale
dc.subject.emtreeMiddle aged
dc.subject.emtreeMonotherapy
dc.subject.emtreeOligoarticular psoriatic arthritis
dc.subject.emtreePatient-reported outcome
dc.subject.emtreePhysician
dc.subject.emtreePolyarticular psoriatic arthritis
dc.subject.emtreePriority journal
dc.subject.emtreePsoriatic arthritis
dc.subject.emtreeRegister
dc.subject.emtreeRemission
dc.subject.emtreeSex difference
dc.subject.emtreeTurkey (republic)
dc.subject.emtreeVisual analog scale
dc.subject.emtreeAge distribution
dc.subject.emtreeAntagonists and inhibitors
dc.subject.emtreeArthritis
dc.subject.emtreePsoriatic
dc.subject.emtreeClinical trial
dc.subject.emtreeComplication
dc.subject.emtreeDaily life activity
dc.subject.emtreeFatigue
dc.subject.emtreeHealth service
dc.subject.emtreeMulticenter study
dc.subject.emtreePathophysiology
dc.subject.emtreeSeverity of illness index
dc.subject.emtreeSex ratio
dc.subject.emtreeTurkey
dc.subject.meshActivities of daily living
dc.subject.meshAge distribution
dc.subject.meshAntirheumatic agents
dc.subject.meshArthritis, psoriatic
dc.subject.meshFatigue
dc.subject.meshFemale
dc.subject.meshHealth services needs and demand
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle aged
dc.subject.meshPatient reported outcome measures
dc.subject.meshRegistries
dc.subject.meshRemission induction
dc.subject.meshSeverity of Illness Index
dc.subject.meshSex distribution
dc.subject.meshTumor necrosis factor-alpha
dc.subject.meshTurkey
dc.subject.meshAdult
dc.subject.scopusComplex; Viscometry; Schiff Bases
dc.subject.wosRheumatology
dc.titleThe psoriatic arthritis registry of Turkey: Results of a multicentre registry on 1081 patients
dc.typeBook
dc.wos.quartileQ1
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/İç Hastalıkları Ana Bilim Dalı/Romatoloji Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Öksüz_vd_2017.pdf
Size:
173.41 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: